Sera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer

References

• Chang SC, Yang WCV. Hyperglycemia, tumorigenesis, and chronic inflammation. Crit Rev Oncol Hematol. 2016;108:146–153.
   PubMed Web of Science ®Google Scholar
• Stattin P, Björ O, Ferrari P, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30:561–567. doi:10.2337/dc06-0922
   PubMed Web of Science ®Google Scholar
• Federico A, Morgillo F, Tuccillo C, et al. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007;121:2381–2386. doi:10.1002/(ISSN)1097-0215
   PubMed Web of Science ®Google Scholar
• Strycharz J, Drzewoski J, Szemraj J, et al. Is p53 involved in tissue-specific insulin resistance formation? Oxid Med Cell Longev. 2017;2017:9270549.
   PubMedGoogle Scholar
• Schisano B, Tripathi G, McGee K, et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011;54:1219–1226. doi:10.1007/s00125-011-2049-0
   PubMed Web of Science ®Google Scholar
• Puzio-Kuter AM. The role of p53 in metabolic regulation. Genes Cancer. 2011;2:385–391. doi:10.1177/1947601911409738
   PubMedGoogle Scholar
• Nag S, Qin J, Srivenugopal KS, Wang M, Zhang R. The MDM2-p53 pathway revisited. J Biomed Res. 2013;27(4):254–271. doi:10.7555/JBR.27.20130030
   PubMedGoogle Scholar
• Kung CP, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol. 2016;231(2):R61–R75. doi:10.1530/JOE-16-0324
   PubMed Web of Science ®Google Scholar
• Ortega-Camarillo C, Guzmán-Grenfell AM, García-Macedo R, et al. Hyperglycemia induces apoptosis and p53 mobilization to mitochondria in RINm5F cells. Mol Cell Biochem. 2006;281:163–171. doi:10.1007/s11010-006-0829-5
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu J, Liang Y, et al. Tumour-associated mutant p53 drives the warburg effect. Nat Commun. 2013;4:2935. doi:10.1038/ncomms3935
   PubMed Web of Science ®Google Scholar
• Tan BS, Tiong KH, Choo HL, et al. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKTdependent suppression of BCL2-modifying factor (BMF). Cell Death Dis. 2015;16:e1826. doi:10.1038/cddis.2015.191
   Google Scholar
• Dong P, Xu Z, Jia N, et al. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway. Mol Cancer. 2009;16:103. doi:10.1186/1476-4598-8-103
   Google Scholar
• Soussi T. p53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 2000;60:1777–1788.
   PubMed Web of Science ®Google Scholar
• Lutz W, Nowakowska-Swirta E. Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process. Int J Occup Med Environ Health. 2002;15:209–218.
   PubMedGoogle Scholar
• Chai Y, Peng B, Dai L, et al. Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma. Scand J Immunol. 2014;80:362–368. doi:10.1111/sji.2014.80.issue-5
   PubMedGoogle Scholar
• PERKENI. Konsesnsus Pengelolaan dan Pencegaham Diabetes Melitus Tipe 2 di Indonesia 2015. PB. PERKENI; 2015.
   Google Scholar
• American Diabetes Association (ADA). 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39:S13–S22. doi:10.2337/dc16-S005
   PubMed Web of Science ®Google Scholar
• Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians. 1999;111(3):241–248. doi:10.1046/j.1525-1381.1999.99220.x
   PubMedGoogle Scholar
• Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102(4):401–414. doi:10.1161/CIRCRESAHA.107.165472
   PubMed Web of Science ®Google Scholar
• Hsu CC, Tseng LM, Lee HC. Role of mitochondrial dysfunction in cancer progression. Exp Biol Med (Maywood). 2016;241(12):1281–1295. doi:10.1177/1535370216641787
   PubMed Web of Science ®Google Scholar
• Shimada H, Ochiai T, Nomura F. Titration of serum p53 antibodies in 1085 patients with various types of malignant tumors a multiinstitutional analysis by the Japan p53 antibody research group. Cancer. 2003;97:682–689. doi:10.1002/(ISSN)1097-0142
   PubMed Web of Science ®Google Scholar
• Abudawood M. Diabetes and cancer: a comprehensive review. J Res Med Sci. 2019;25(24):94. doi:10.4103/jrms.JRMS_242_19
   Google Scholar
• Orgel E, Mittelman SD. The links between insulin resistance, diabetes, and cancer. Curr Diab Rep. 2013;13(2):213–222. doi:10.1007/s11892-012-0356-6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhou J, Wang T, Cai L. High level glucose increases mutagenesis in human lymphoblastoid cells. Int J Biol Sci. 2007;3(6):375–379. doi:10.7150/ijbs.3.375
   PubMed Web of Science ®Google Scholar
• Kim D, Ahn BN, Kim Y, et al. High glucose with insulin induces cell cycle progression and activation of oncogenic signaling of bladder epithelial cells cotreated with metformin and pioglitazone. J Diabetes Res. 2019;2019:2376512. doi:10.1155/2019/2376512
   PubMedGoogle Scholar
• Suppiah A, Greenman J. Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer. World J Gastroenterol. 2013;19:4651–4670. doi:10.3748/wjg.v19.i29.4651
   PubMed Web of Science ®Google Scholar
• Soussi T. The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy. Immunol Today. 1996;17:354–356. doi:10.1016/0167-5699(96)30019-4
   PubMedGoogle Scholar
• Angelopoulou K, Diamandis EP, Sutherland DJA, et al. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. Int J Cancer. 1994;58:480–487. doi:10.1002/ijc.2910580404
   PubMed Web of Science ®Google Scholar
• Di Cesare E, Previti M, Lombardo F, et al. Serum Anti-p53 autoantibodies in patients with type 1 diabetes. Ann Clin Lab Sci. 2001;31:253–258.
   PubMedGoogle Scholar
• Rodriguez OC, Choudhury S, Kolukula V, et al. Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle. 2012;11:4436–4446. doi:10.4161/cc.22778
   PubMed Web of Science ®Google Scholar
• Morselli E, Tasdemir E, Maiuri MC, et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle. 2008;7:3056–3061. doi:10.4161/cc.7.19.6751
   PubMed Web of Science ®Google Scholar
• Karantza-Wadsworth V, Patel S, Kravchuk O, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 2007;21:1621–1635. doi:10.1101/gad.1565707
   PubMed Web of Science ®Google Scholar
• Mathew R, Kongara S, Beaudoin B, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007;21:1367–1381. doi:10.1101/gad.1545107
   PubMed Web of Science ®Google Scholar
• Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011;25:795–800. doi:10.1101/gad.2016211
   PubMed Web of Science ®Google Scholar
• Visconti R, Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Discov Devel. 2009;12:240–245.
   PubMed Web of Science ®Google Scholar
• Mathew R, Karp CM, Beaudoin B, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137:1062–1075. doi:10.1016/j.cell.2009.03.048
   PubMed Web of Science ®Google Scholar
• Sun B, Karin M. Inflammation and liver tumorigenesis. Front Med. 2013;7:242–254. doi:10.1007/s11684-013-0256-4
   PubMed Web of Science ®Google Scholar
• Hoshino A, Ariyoshi M, Okawa Y, et al. Inhibition of p53 preserves parkin-mediated mitophagy and pancreatic β-cell function in diabetes. Proc Natl Acad Sci. 2014;111:3116–3121. doi:10.1073/pnas.1318951111
   PubMed Web of Science ®Google Scholar
• Tasdemir E, Maiuri MC, Galluzzi L, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol. 2008;10:676–687. doi:10.1038/ncb1730
   PubMed Web of Science ®Google Scholar
• Guo JY, Chen HY, Mathew R, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011;25:460–470. doi:10.1101/gad.2016311
   PubMed Web of Science ®Google Scholar
• Lock R, Roy S, Kenific CM, et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell. 2011;22:165–178. doi:10.1091/mbc.e10-06-0500
   PubMed Web of Science ®Google Scholar
• Strohecker AM, Guo JY, Karsli-Uzunbas G, et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013;3:1272–1285. doi:10.1158/2159-8290.CD-13-0397
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12:401–410. doi:10.1038/nrc3262
   PubMed Web of Science ®Google Scholar